Market Closed -
Other stock markets
|
After market 01:07:26 pm | |||
1.295 EUR | -6.83% | 1.293 | -0.15% |
12:46pm | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
May. 15 | Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.08% | 37.08M | |
+7.78% | 115B | |
+12.87% | 107B | |
-13.55% | 22.31B | |
-3.99% | 21.6B | |
-6.59% | 18.23B | |
-39.93% | 17.62B | |
+6.85% | 14.26B | |
+33.10% | 12.37B | |
-27.85% | 8.28B |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- Transcript : Medigene AG, 2020 Earnings Call, Mar 25, 2021